|
 |
ORIGINAL ARTICLE |
|
Year : 2011 | Volume
: 14
| Issue : 2 | Page : 146-150 |
|
Surgical consideration for benign bone tumors
SU Eyesan1, OK Idowu1, DC Obalum2, OE Nnodu3, FB Abdulkareem4
1 Department of Orthopedics and Trauma Surgery, National Orthopedic Hospital, Igbobi, Lagos, Yaba, Lagos, Nigeria 2 Department of Surgery, National Orthopedic Hospital, Igbobi, Lagos, Yaba, Lagos, Nigeria 3 Department of Pathology, National Orthopedic Hospital, Igbobi, Lagos, Yaba, Lagos, Nigeria 4 Department of Pathology and Morbid Anatomy, National Orthopedic Hospital, Igbobi, Lagos, Yaba, Lagos, Nigeria
Date of Acceptance | 05-Mar-2011 |
Date of Web Publication | 19-Aug-2011 |
Correspondence Address: S U Eyesan Department of Orthopaedics and Trauma Surgery, National Orthopaedic Hospital, Igbobi, Lagos,Pmb 2009, Yaba, Lagos Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1119-3077.84003
Abstract | | |
Background: The surgical management of symptomatic benign bone tumor has been described in various manners in medical literature. However, there are few published reports on the presentation and surgical management of benign bone tumors in black African patients. Objectives: To determine the pattern of presentation of benign bone tumors and evaluate the common indications for surgery in a Nigerian Orthopedic Center. Materials and Methods: This is a prospective study of 67 patients, surgically treated for benign bone tumors, over a three-year period, at the National Orthopedic Hospital, Lagos, Nigeria. Results: The common histological types include, osteochondroma, giant cell tumor, and the simple bone cyst. These tumors have varying anatomic locations, but are more commonly located around the knee joint. In this series, most of the patients have presented with an active or aggressive stage of the disease. The most common indication for surgery is painful swelling; other indications include a pathological fracture, restricted range of movement, and peripheral nerve compression. The surgical procedures performed are simple excision, curettage, and stabilization; and 1-stage and 2-stage wide resection with reconstruction. Patients with significant bone defects have autologous bone grafting or methylmethacrylate cement application. Further stabilization is achieved with intramedullary or compression plate and screw fixation. Amputation has only been necessary in one patient with a huge aneurysmal bone cyst. At the average follow-up period of 28.6 months, five patients showed recurrence. All were with a histological diagnosis of giant cell tumor. Conclusions: The mode of presentation of benign bone tumors in this group of black African patients is heterogenous, demanding various surgical options. Limb sparing is a largely feasible option, but the recurrence rate is particularly higher for giant cell tumors. Increase in the number of patients presenting with giant cell tumors raises the possibility of an increase in the incidence of this condition in the black African population. Larger multicenter studies in the black African population may shed more light on the actual incidence of giant cell tumors and other bone tumors in this group of patients. Keywords: Surgery in benign bone tumours, black African tumours, giant cell tumours, osteochondroma
How to cite this article: Eyesan S U, Idowu O K, Obalum D C, Nnodu O E, Abdulkareem F B. Surgical consideration for benign bone tumors. Niger J Clin Pract 2011;14:146-50 |
Introduction | |  |
Benign bone tumors represent a diverse group of neoplasms occurring in the bony skeleton. These tumors have been reported to have different patterns of clinical presentation and aggressiveness, hence the worldwide variability in modes of surgical treatment. [1],[2],[3],[4],[5],[6]
The actual incidence of benign bone tumors is still shrouded in controversy; this is because many patients are asymptomatic, and the tumors remain largely undetectable. [7],[8],[9],[10],[11] Previous reports have revealed that some benign bone tumors [e.g., non-ossifying fibroma] have a high incidence in childhood, but are rare after skeletal maturity, suggesting that there must be some spontaneous resolution. [12] The diagnoses of many non-aggressive tumors are made when radiographs are taken for other conditions, because tumors in the latent stage rarely require surgical treatment. Surgical consideration is important for confirmation of diagnosis [where this is doubtful], management of complications [e.g., pathological fractures, growth disturbances, restricted movement], and in the control of aggressive lesions. [13],[14]
Reports on the presentation and surgical treatment of benign bone tumors in the Black African patients are scanty. We carried out this study to highlight the mode of presentation, surgical options, and outcome of the treatment for benign bone tumors, in patients presenting at a tertiary musculoskeletal center.
Materials and Methods | |  |
A prospective study was performed in patients surgically managed for benign bone tumors, between January 2003 and July 2005, at the National Orthopedic Hospital, Lagos. All the procedures were performed by the same team of surgeons and informed consent was obtained from the patients before participation in the study. In each case, the neoplastic lesion was resected following the widely approved oncological principles. These entailed preoperative planning based on plain radiographs, in a majority of the patients. A wide resection with a fringe of normal tissue was obtained for all aggressive lesions.
Bio-data including age, sex, presenting complaint, anatomic location of the lesion, stage of disease, diagnosis, and surgical options were recorded on a proforma. The follow-up period was calculated from the day of operation and the average follow-up period was 28.6 months.
Results | |  |
Patients
A total of 67 patients [mean age of 26.4 years] were treated for benign bone tumors, surgically [Figure 1]. There was a slight male preponderance with a male to female ratio of 1.6: 1.
The common indications for surgery included, painful swelling [62.7%], cosmetic problems [16.4%], restricted movements [10.5%], nerve compression [6.0%], and pathological fractures [4.5%] [Figure 2].
Anatomic location
A large number of patients presented with tumors located around the knee joint, that is, distal femur [28.6%] and proximal tibia [20.6%]. A large percentage of the tumors occurred around the wrist joint [15.9%] and around the ankle [14.3%] [Figure 3].
Histological type
Osteochondroma was the histological diagnosis in 33 patients [49.2%], while giant cell tumor and simple bone cyst were the histological diagnoses in 28.4 and 7.0% of the patients. Benign bone tumors such as non-ossifying fibroma, aneurysmal bone cyst, enchondroma, benign fibrous histiocytoma, and chondromyxoid fibroma were also recorded in some patients [Figure 4].
Surgical options
One stage resection and reconstruction for aggressive tumors was undertaken in 17.9% of the patients [Figure 5]. However, for large and aggressive tumors amenable to limb salvage, the procedures were conducted in two stages. The resection of such a lesion was undertaken as the first stage of the procedure [Figure 6],[Figure 7],[Figure 8]. Next, stabilization using a compression plate and screw or an intramedullary nail was performed in 10.5%, as the second stage of surgery [Table 1]. | Figure 5 : Aneurysmal bone cysts proximal humerus. Pre- and postoperative radiographs
Click here to view |
 | Figure 8 : Non-ossifying fibroma of femur, presenting with pathological fracture
Click here to view |
Surgical options in patients with active and moderate-size tumors [5-10 cm] included curettage or simple excision in conjunction with cancellous bone grafting or methylmethacrylate cement application. Limb salvage was impossible in one patient with a large aneurysmal bone cyst encasing the popliteal vessels and the tibia nerve [Figure 6]. This patient was offered an above-knee amputation.
Complications included significant limb length discrepancies in 10.5%, deep postoperative infection in 4.5%, and nerve injury in 2.9%. There was recurrence in five patients, all with the diagnosis of giant cell tumor. This represented 27.8% of all recorded giant cell tumors.
Discussion | |  |
Benign bone tumors present as varied clinical and pathological entities, and the diagnoses can be a source of great anxiety for the patients, relatives, and the attending physician. [3],[11],[15],[16] The age range for the patients in this study further confirms the belief that benign bone tumors are predominantly a disease of the younger population. [8],[10],[11],[16] The anatomic locations and the recorded diagnoses in these patients were similar to the previously reported patterns in medical literature. [7],[8],[9],[10],[15] This study recorded many large benign bone tumors, suggesting a delay in presentation at the tertiary healthcare center. The illness behavior of population groups, poor socioeconomic condition, and inadequacy of the healthcare facilities have been adduced as reasons for treatment delays in patients with bone tumors. [17],[18] Further studies on the referral pattern for patients with bone tumors, and evaluation of reasons for delay in presentation at the tertiary musculoskeletal centers among Nigerian patients, will be necessary. Although previous workers have identified giant cell tumors in approximately 14-20% of the benign bone tumor series, [8],[9],[10],[19],[20],[21],[22],[23] this hospital-based study recorded a larger proportion of patients surgically treated for giant cell tumors. This apparent high incidence may be attributable to the compelling need to seek surgical intervention on account of the large size of giant cell tumors. Larger multicenter studies in the black African population may shed more light on the actual incidence of giant cell tumors and other bone tumors in this group of patients.
Most of the lesions requiring surgery were located in the long bones, that is, femur, tibia, radius, fibula, and humerus. The anatomic location and the tumor size posed serious challenges in treatment planning. Hence, various surgical options such as stage one or stage two resection and reconstruction were adopted.
The single stage resection and reconstruction entails complete resection of the tumor with a 2.5 cm margin, free fibula grafting, and fixation with plate and screws at the same sitting. Where the tumor margin is extensive, the operations are conducted in two stages, in order to reduce intraoperative blood loss and to achieve a good resection margin. Cancellous bone grafting after curettage is also a common procedure. This procedure is offered to patients with small-sized giant cell tumors and bone cysts.
The use of bone cement in conjunction with plate and screws was offered to patients with a significant bone defect, after a wide resection. Capanna et al., and Trieb et al., had previously reported reduction in recurrence rate following a wide resection, for giant cell tumor. [24],[25] There was no major complication directly related to the use of bone cement in patients recorded in this study. Carmargo et al., reported no significant deleterious effects with cement usage in aggressive benign tumors after a long-term follow-up. [15] The average cost of a pack of methylmetacrylate cement was 100 USD, which was expensive for many patients in this series. Controversy still rages on about the management of large aneurysmal bone cysts. Aneurysmal bone cysts are mysterious in their clinical characteristics and pathomorphology. Several theories, including that of secondary hemorrhagic events in pre-existing neoplasms have been adduced. The management of this condition is also fraught with great challenges, both in diagnosis and surgical treatment. Recurrence rate as high as 20% has been reported from various centers. [26],[27],[28]
This study reported an above-knee amputation in a young patient with a huge aneurysmal bone cyst of the proximal tibia. This was performed after proper evaluation of the available facilities for reduction of intraoperative blood loss and the extent of postoperative morbidity. This may well mean that amputation may be the last resort in circumstances where endoprosthetic reconstruction is not affordable. Recurrence occurred in five patients with giant cell tumor; this further confirmed the propensity for recurrence of giant cell tumor of bone after surgical resection. [20],[21],[24],[25]
References | |  |
1. | Kreicbergs A, Lonnqvist PA, Nilsson B. Currettage of benign lesions of bone: Factors related to recurrence. Int orthop 1985;8:287-94.  |
2. | Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O'Donnell RJ. Local control of long bone giant cell tumor using curettage, burring and bone grafting without adjuvant therapy. Int Orthop 2006;30:495-8.  [PUBMED] [FULLTEXT] |
3. | Schaser KD, Bail HJ, Haas NP, Melcher I. Treatment concepts of benign bone tumors and tumor-like bone lesions. Chirurg 2002;73:1181-90.  [PUBMED] [FULLTEXT] |
4. | Liu H, Sun J, Wang Y, Yang X, Zhu E. Repairing bone defects of benign bone neoplasm by grafting of bioactive glass combined with autologous bone marrow. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2008;22:1349-53.  [PUBMED] |
5. | Bottner F, Rodl R, Kordish I, Winklemann W, Gosheger G, Lindner N. Surgical treatment of symptomatic osteochondroma. A three to eight-year follow-up study. J Bone Joint Surg Br 2003;85:1161-5.  [PUBMED] [FULLTEXT] |
6. | Sung AD, Anderson ME, Zurakowski D, Hornicek FJ, Gebhardt MC Unicameral bone cyst: A retrospective study of three surgical treatments. Clin Orthop Relat Res 2008;466:2519-26.  |
7. | Bahebeck J, Atagana R, Eyenga V, Pisoh A, Sando Z, Hoffmeyer P. Bone tumors in Cameroon: Incidence, Demography and Histopathology. Int Orthop 2004;7:315-7.  |
8. | Baena-Ocampo Ldel C, Ramirez-Perez E, Linares-Gonzalez LM, Delgado-Chavez R. Epidemiology of bone tumors in Mexico City: Retrospective clinicopathologic study of 566 patients at a referral institution. Ann Diagn Pathol 2009;13:16-21.  [PUBMED] [FULLTEXT] |
9. | Abdulkareem FB, Eyesan SU, Akinde OR, Ezembakwe ME, Nnodu OE. Pathological study of bone tumorsat the National Orthopedic Hospital, Lagos, Nigeria. West Afr J Med 2007;26:306-11.  [PUBMED] |
10. | Blackwell JB, Curnow MN. Benign bone tumors in Western Australia, 1972-1996. Pathology 2007;39:567-74.  [PUBMED] [FULLTEXT] |
11. | Vlychou M, Athanasou NA. Radiological and pathological diagnosis of paediatric bone tumors and tumor-like lesions. Pathology 2008;40:196-216.  [PUBMED] [FULLTEXT] |
12. | Malghem J, Maldague B, Esselinckx W, Noel H, De Nayer P, Vincent A. Spontaneous healing of aneurysmal bone cyst. J Bone Joint Surg Br 1989;71:645-50.  [PUBMED] [FULLTEXT] |
13. | Enneking WF. A system of staging musculoskeletal neoplasm. Clin Orthop 1986;153:159.  |
14. | Kreicbergs A, Lonnqvist PA, Nilsson B. Currettage of benign lesions of bone: Factors related to recurrence. Int Orthop 1985;8:287-329.  |
15. | Carmargo OP, Croci AT, Oliveira CR, Baptista AM, Caiero MT. Functional and radiographic evaluation of 214 aggressive benign bone lesions treated with curettage, cauterization, and cementation: 24 years of follow-up. Clinics 2005;60:439-44.  |
16. | Aboulafia AJ, Kennon RE, Jelinek JS. Benign bone tumors of childhood. J Am Acad Orthop Surg 1999;7:377-88.  [PUBMED] [FULLTEXT] |
17. | Schnurr C, Pippan M, Stuetzer H, Delank KS, Michael JW, Eysel P. Treatment delay of bone tumors, compilation of a sociodemographic risk profile: A retrospective study. BMC Cancer 2008;23:8-22.  |
18. | Eyesan SU, Obalum DC, Nnodu OE, Abdulkareem FB, Ladejobi AO. Challenges in the diagnosis and management of musculoskeletal tumors in Nigeria. Int Orthop 2009;33:211-3.  [PUBMED] [FULLTEXT] |
19. | Odetayo OO. Pattern of bone tumors at the National Orthopedic Hospital, Lagos, Nigeria. West Afr J Med 2001;20:161-4.  [PUBMED] |
20. | Haque AU, Moatasim A. Giant cell tumor of bone: A neoplasm or a reactive condition? Int J Clin Exp Pathol 2008;1:489-501.  [PUBMED] [FULLTEXT] |
21. | Arbeitsgemeinschaft Knochentumoren, Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, et al. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am 2008;90:1060-7.  [PUBMED] [FULLTEXT] |
22. | Sung H, Kuo D, Shu W, Chai YB, Liu CC, Li SM. Giant cell tumor of bone:Analysis of 208 cases in Chinese patients. J Bone Joint Surg Am 1982;64:755-61.  |
23. | Yip K, Leung P, Kumta S. Giant cell tumor of bone. Clin Orthop 1996;523:60.  |
24. | Capanna R, Fabbri N, Bettelli G. Curettage of giant cell tumor of bone. The effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov 1990;75:206.  [PUBMED] |
25. | Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R. Recurrence of curetted and bone-grafted giant-cell tumors with and without adjuvant phenol therapy. Eur J Surg Oncol 2001;27:200-2.  [PUBMED] [FULLTEXT] |
26. | Diercks RL, Sauter AJ, Mallens WM. Aneurysmal bone cyst in association with fibrous dysplasia. A case report. J Bone Joint Surg Br 1986;68:144-6.  [PUBMED] [FULLTEXT] |
27. | Mankin HJ, Hornicek FJ, Ortiz-Cruz E, Villafuerte J, Gebhardt MC. Aneurysmal bone cyst: A review of 150 patients. J Clin Oncol 2005;23:6756-62.  [PUBMED] [FULLTEXT] |
28. | Mei J, Gao YS, Wang SQ, Cai XS. Malignant transformation of aneurysmal bone cysts: A case report. Chin Med J (Engl) 2009;122:110-2.  [PUBMED] [FULLTEXT] |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8]
[Table 1]
This article has been cited by | 1 |
Benign Bone Tumors: An Overview of What We Know Today |
|
| Sara De Salvo, Vito Pavone, Sebastiano Coco, Eleonora Dell’Agli, Chiara Blatti, Gianluca Testa | | Journal of Clinical Medicine. 2022; 11(3): 699 | | [Pubmed] | [DOI] | | 2 |
Treatment alternatives and clinical outcomes of bone filling after benign tumour curettage. A systematic review |
|
| Nelson Fabrício Gava,Edgard Eduard Engel | | Orthopaedics & Traumatology: Surgery & Research. 2021; : 102966 | | [Pubmed] | [DOI] | | 3 |
Management of benign bone tumors in a tertiary hospital in North West Nigeria |
|
| MI Maitama,YZ Lawal,LI Dahiru,FS Ejagwulu,KE Amaefule | | Archives of International Surgery. 2020; 10(3): 95 | | [Pubmed] | [DOI] | | 4 |
A palaeoepidemiological investigation of osteomata, with reference to medieval Poland |
|
| Thomas Siek,Carolyn Rando,Agata Cieslik,Anna Spinek,Tony Waldron | | International Journal of Osteoarchaeology. 2020; | | [Pubmed] | [DOI] | | 5 |
Symptom Interval in Cases of Benign Cystic Lesions of Bone and its correlation with Surgical Intervention |
|
| Aakriti Jain,Sitanshu Barik,Roop Bhushan Kalia,Shobha S. Arora,Nikhil Goyal | | Indian Journal of Orthopaedics. 2020; | | [Pubmed] | [DOI] | | 6 |
Isolated primary bone tumours of the lesser trochanter: Demographics, diagnosis and management |
|
| A. Saad,U. Hanif,S. Evans,A. Iqbal,M. Davies,S. James,R. Botchu | | Journal of Clinical Orthopaedics and Trauma. 2019; | | [Pubmed] | [DOI] | | 7 |
In defence of the osteoma: The relevance of benign tumours in bioarchaeology and palaeo-oncology |
|
| Thomas Siek | | International Journal of Osteoarchaeology. 2019; | | [Pubmed] | [DOI] | | 8 |
A CLINICO PATHOLOGICAL STUDY OF BENIGN TUMORS OF THE BONE IN NORTHERN KERALA |
|
| Vidyadhar Rao | | Journal of Evidence Based Medicine and Healthcare. 2016; 3(10): 288 | | [Pubmed] | [DOI] | | 9 |
Benign Tumours of the bone: A review |
|
| D.N. Hakim,T. Pelly,M. Kulendran,J.A. Caris | | Journal of Bone Oncology. 2015; | | [Pubmed] | [DOI] | | 10 |
Accuracy of fine needle aspiration cytology in the diagnosis of bone lesions with radiological assistance: Experience from the National Cancer Institute, Cairo University, Egypt |
|
| Ahmed Mohamed Aly,Hebatallah M. Shaaban,Iman Abou-Sinna | | The Egyptian Journal of Radiology and Nuclear Medicine. 2013; | | [Pubmed] | [DOI] | | 11 |
Benign lytic lesions of the femoral neck: Mid-term results of extended curettage and sartorius muscle pedicle bone grafting |
|
| Kundu, Z.S. and Gogna, P. and Sangwan, S.S. and Garg, R. and Kamboj, P. and Singla, R. | | Archives of Orthopaedic and Trauma Surgery. 2013; 133(4): 457-462 | | [Pubmed] | | 12 |
Benign lytic lesions of the femoral neck: mid-term results of extended curettage and sartorius muscle pedicle bone grafting |
|
| Zile Singh Kundu,Paritosh Gogna,Sukhbir Singh Sangwan,Rakesh Garg,Pradeep Kamboj,Rohit Singla | | Archives of Orthopaedic and Trauma Surgery. 2013; 133(4): 457 | | [Pubmed] | [DOI] | | 13 |
Value of image-guided fine-needle aspiration cytology in the diagnosis of bone lesions |
|
| HebatAllah M. Shaaban,Ahmed M. Aly,Iman Abou-Sinna | | Egyptian Journal of Pathology. 2013; 33(1): 18 | | [Pubmed] | [DOI] | |
|
 |
 |
|